Cervical cancer: open trials in Thailand

6 open trials have a site in Thailand. Registry data; only the trial team decides who can take part.

NCT07216703
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Ramathibodi Hospital ( Site 3404), Bangkok · Faculty of Medicine Siriraj Hospital ( Site 3401), Bangkok · Chulalongkorn University ( Site 3403), Bangkok · Maharaj Nakorn Chiang Mai Hospital ( Site 3402), Chiang Mai
Registry updated 2026-10-29
NCT06079671
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Trial Treatment · Phase 3 · AstraZeneca
Bangkok · Muang · Udon Thani
Registry updated 2026-09-30
NCT07709650
Hypofractionated Chemoradiotherapy for Cervical Cancer
Trial Treatment · Phase 3 · Mahidol University
Siriraj Hospital, Bangkok Noi
Registry updated 2026-08-24
NCT07595224
Postoperative Hypofractionated Whole Pelvic Radiotherapy in Cervical and Endometrial Cancer
Trial Treatment · Siriraj Hospital
Siriraj Hospital, Bangkok
Registry updated 2026-05-19
NCT05570422
A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01
Trial Treatment · Phase 1 · Kortuc, Inc.
Bangkok · Chiang Mai
Registry updated 2026-04-08
NCT07196033
Asian Gynecological Brachytherapy Registry in Cervical Cancer
Research · Tata Memorial Hospital
Mahidol University, Bangkok · Chiang Mai University, Chiang Mai
Registry updated 2026-02-09

This page is not medical advice. Talk to your doctor before contacting a trial.

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)